Exclusive

Publication

Byline

Location

Clinical Trial: The effects of nutritional support combined with rehabilitation therapy on patients with dysphagia after stroke (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effects of nutritional support combined with rehabilitation therapy on patients wi... Read More


Clinical Trial: Improving Pathogen Detection Efficiency in Peritoneal Dialysis-Associated Peritonitis by Targeted Next-Generation Sequencing: Technical Implementation and Clinical Evaluation (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Improving Pathogen Detection Efficiency in Peritoneal Dialysis-Associated Peritonitis ... Read More


Clinical Trial: A Study on the Efficacy of Sivelestat Sodium in the Treatment of Sepsis Patients with ARDS (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy of Sivelestat Sodium in the Treatment of Sepsis Patients with ... Read More


Clinical Trial: Research on the Construction of a Fetal Position Visualization and Left/Right Identification Model Based on Artificial Intelligence (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Construction of a Fetal Position Visualization and Left/Right Identifi... Read More


Clinical Trial: OSCC serum biomarker (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'OSCC serum biomarker'. The following are the other relevant details related to the tri... Read More


Clinical Trial: A Phase II, Single-Arm, Single-Center Clinical Trial of Vebreltinib Enteric Capsules in Combination with Bevacizumab and Temozolomide in Patients with Recurrent/Progressive High-Grade Glioma (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase II, Single-Arm, Single-Center Clinical Trial of Vebreltinib Enteric Capsules i... Read More


Clinical Trial: Research on Key Technologies for Intelligent Precision Radiotherapy of Brain and Liver Tumors Based on Multimodal Imaging Integration (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on Key Technologies for Intelligent Precision Radiotherapy of Brain and Liver... Read More


Singapore Clinical Trial: A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD0120, an Autologous Dual Targeting Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19, versus Autologous Stem Cell Transplant (ASCT) in Participants with Newly Diagnosed Multiple Myeloma who are Transplant Eligible (TE NDMM) (DURGA-6)

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More


Singapore Clinical Trial: A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or without Bevacizumab in Comparison to Active Observation with or without Bevacizumab as Maintenance Treatment in Participants with Newly Diagnosed FIGO Stage III/IV Non-Homologous Recombination Deficient Ovarian Cancer

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event – MOVE-Lp(a)

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muval... Read More